The August Lockup Wall: SpaceX, the IPO Pipeline, and the End of the Buyback Era

SpaceX priced 555.6 million shares at $135 on June 11, 2026, raising $75 billion in the largest IPO in U.S. history.^[1] Five weeks later, the stock sits at $119.85, down 21% over seven consecutive sessions and 47% below its June 16 intraday high of $225.64.^[2] It has traded below its $135 IPO price since mid-July.^[3]

That is a dramatic round-trip. But the more important story is not SpaceX’s stock price — it is what the lockup calendar, the IPO pipeline, and the reversal of a two-decade buyback era reveal about the structural plumbing of U.S. equity markets in the second half of 2026.

Three forces are converging: a wall of insider lockup supply arriving in August, a pipeline of mega-IPOs behind SpaceX that could push net equity issuance toward $1.5 trillion over the next two years,^[4] and a simultaneous Treasury bill issuance wave that is draining the liquidity these new offerings need to absorb cleanly. This is not a sentiment problem. It is a supply-and-demand mechanics problem, and the calendar says the test arrives in August.

The August 6 Lockup Wall

SpaceX’s IPO sold 639 million shares (including the greenshoe) to the public — roughly 4.2% of its total shares outstanding.^[1][3] The lockup structure means that a vastly larger pool of restricted shares becomes eligible for sale once SpaceX reports second-quarter results, projected for August 4 after the close.^[2]

According to SEC filings, up to 911.5 million Class A shares become eligible for transfer on August 6 — the second full trading day after the earnings release. At the July 21 closing price of $119.85, that block is worth approximately $109 billion, or 143% of the shares sold in the IPO itself.^[2] An additional 455.8 million shares could unlock if the stock closes at or above $175.50 for five of ten consecutive sessions surrounding the earnings date — a condition that looks remote at current prices, given that $175.50 is 46% above Monday’s close.^[2][3]

Source: ts2.tech analysis of SpaceX SEC filings, July 21, 2026.^[2] Eligibility does not guarantee that all holders will sell.

The mechanics are straightforward: a stock with only 4.2% of its shares in public float trades on scarcity.^[1] When that float can roughly quadruple in a single window, the price-discovery process changes fundamentally. The peer-reviewed literature on IPO lockups, spanning 2,529 firms from 1988 to 1997, found statistically significant negative abnormal returns of approximately 1.5% in the days surrounding lockup expiration, with the effect concentrated in venture-backed technology firms.^[1] SpaceX is precisely that type of firm.

The Buyback Era Is Ending — and Issuance Is Replacing It

For nearly two decades, U.S. corporations vacuumed up their own shares faster than they issued new ones — a phenomenon known as “de-equitization” that shrank the total supply of U.S. equity and provided a persistent tailwind for stock prices.^[4] JPMorgan now estimates that net equity supply could reach $1.2 to $1.5 trillion over the next two years, ending the shrinkage era.^[4]

Fidelity’s Jurrien Timmer has argued that this shift is already visible: share counts have been rising since 2023, and buybacks are declining as a percentage of earnings, squeezed by surging AI capital expenditure that competes for the same corporate cash.^[5] The AI capex cycle — which has driven memory chip costs to more than double since 2025, with further doubling expected by fall 2027 — is consuming the cash that previously funded repurchase programs.^[1]

The implications go beyond any single company. When corporate America was the largest net buyer of its own stock, the market had a structural bid. If corporations become net issuers — funding AI infrastructure, defense contracts, and space programs with new equity rather than buybacks — the market must find a new buyer to absorb that supply. That buyer, for the moment, is unclear.

The Pipeline Behind SpaceX

SpaceX was not the peak of the IPO cycle. It was the opening act.

Anthropic confidentially filed its S-1 on June 1, 2026, becoming the first frontier AI lab to formally initiate the IPO process, with a May 28 Series H round valuing the company at $965 billion post-money.^[6] Bankers are reportedly scheduling investor meetings, with an October listing target.^[6] OpenAI filed its own confidential S-1 one week later.^[6]

The broader 2026 pipeline includes over 50 companies, with Lambda (AI infrastructure), Perplexity, Cohere, Shield AI, Shein, Revolut, and others at various stages of filing.^[7] Cerebras, which went public earlier this year, demonstrated that the AI-hardware sector has appetite for new listings.^[7]

But SpaceX’s post-IPO performance is casting a shadow. CNBC reported on July 17 that the sagging stock “dampens the mood” for blockbuster IPOs.^[8] Sam Lessin of Slow Ventures noted that the pipeline faces a challenge: “It’s very hard to care about anything other than the $3 trillion potential IPOs that, in theory, are going to happen in the next year.”^[7] PitchBook has explored scenarios where OpenAI delays its IPO to 2027 if market conditions deteriorate.^[7]

The risk is circular: if SpaceX’s lockup expiry drives further selling, it weakens the window for the very IPOs that the market needs to price successfully. A failed or poorly received mega-IPO does not just hurt one company — it resets valuation expectations for the entire queue.

Index Inclusion: Forced Buying Meets Forced Selling

The structural complexity does not stop with lockups. The three major index providers diverged sharply on how to handle mega-IPOs, and the divergence creates mechanical buying and selling that is largely independent of fundamentals.^[1]

• S&P 500: Maintained its existing rules — 12-month seasoning, GAAP profitability in the most recent quarter and cumulatively over trailing four quarters, and minimum float requirements. SpaceX, which posted a $4.94 billion net loss in 2025, is ineligible until at least mid-2027.^[1]
• Nasdaq-100: Revised methodology effective May 1, 2026, allowing any newly listed company in the top 40 by market cap to enter after just 15 trading days, with no minimum float requirement.^[1]
• FTSE Russell: Relaxed its 5% float minimum; confirmed SpaceX enters the Russell 1000 at the September or December 2026 reconstitution.^[1]
• MSCI: Retained its 10-trading-day inclusion rule (in place since 2007). CRSP allows fast-track inclusion after 5 trading days.^[1]

Bloomberg Intelligence estimates that passive funds tracking the Nasdaq-100 and Russell 1000 will need to acquire shares equal to approximately 24% of SpaceX’s public float, with a subsequent S&P 500 inclusion adding another 19%. Goldman Sachs estimates the Nasdaq-100 inclusion alone could trigger up to $60 billion in forced buying.^[1]

But forced buying is also forced selling. When SpaceX enters the Nasdaq-100 at an estimated 0.47% to 0.70% weight, index funds must fund the purchase by proportionally trimming every other constituent — roughly $70 million of selling per stock across the other 100 names.^[1] For the largest names, that is a rounding error. For smaller constituents, it is more material. The Tesla precedent in December 2020 — when 69 million shares worth approximately $50 billion traded in the closing auction alone on inclusion day — shows how concentrated and violent this mechanical buying can be.^[1]

The Liquidity Drain in the Background

While the equity supply pipeline expands, the Treasury is simultaneously draining market liquidity. The U.S. Treasury is sharply increasing weekly T-bill issuance in July, reversing the paydowns that supported risk assets earlier in the year.^[9] The Treasury General Account is expected to rise by approximately $100 billion, with funds sourced from markets.^[9]

With the Federal Reserve’s reverse repo facility usage near zero, new T-bill issuance draws more directly on market liquidity rather than being absorbed by idle reserves.^[9] Historically, periods of high T-bill issuance have pressured equities and other risk assets, while paydown periods have supported rallies.^[9] The Warsh Fed’s hawkish tilt — holding rates at 3.50%-3.75% in June with nine of eighteen committee members projecting at least one hike in 2026 — adds a rate backdrop that is less accommodative than the one that nurtured the previous IPO cycle.^[1]

The combination matters: a market asked to absorb $109 billion in newly unlocked SpaceX shares, an approaching Anthropic IPO, and $1.5 trillion in projected net equity supply over two years is doing so while Treasury issuance is actively competing for the same pool of investable dollars.

What to Watch Next

1. August 4–6: SpaceX Q2 earnings and lockup expiry. The earnings release after close on August 4 unlocks the first wave of 911.5 million shares on August 6.^[2] The price reaction around this window is the single most important data point for the rest of the 2026 IPO calendar.

2. Starship Flight 13, July 23. SpaceX has scheduled its next Starship test for Thursday, July 23, with a 20-satellite Starlink deployment mission.^[2] A successful launch could stabilize sentiment ahead of the lockup expiry; an aborted attempt (as happened on July 17) would compound the selling pressure.

3. Anthropic’s pricing and timing. Investor meetings are reportedly underway for an October listing.^[6] If SpaceX’s lockup expiry goes poorly, the pricing window for the next mega-IPO narrows.

4. Nasdaq-100 inclusion mechanics. SpaceX’s entry into the Nasdaq-100 will trigger proportional selling across the other 100 constituents.^[1] Watch for front-running by active traders in the days before the effective date.

5. Treasury T-bill issuance cadence through early September. The pace of T-bill supply determines how much investable capital is available to absorb new equity issuance.^[9] A persistent drain constrains the market’s capacity to price large offerings without discounting.

6. Morningstar’s $63 fair value. Morningstar set a fair value of $63 per share for SpaceX, describing it as “the result of mathematics more than skepticism.”^[2] Shares closed Monday at $119.85 — 90% above that estimate. How the market closes that gap, and how quickly, tells us whether the post-IPO selloff is a correction toward fundamentals or a liquidity-driven overshoot.

The story of mid-2026 is not that one stock fell. It is that the structural forces that supported U.S. equities for two decades — shrinking supply, relentless buybacks, abundant liquidity — are reversing simultaneously. The SpaceX lockup expiry on August 6 is the first real stress test of whether the market can absorb the new supply era without a broader repricing. If it can, the IPO pipeline clears and the cycle continues. If it cannot, the mega-IPO window closes, valuations reset downward, and the Anthropics and OpenAIs of the world wait for better weather.

The answer arrives in weeks, not quarters.

FN2 Research provides market commentary and education, not personalized investment advice.